Amigo Rebrands as Concurrence
Amigo is rebranding as Concurrence, the company announced in a press release. The clinical AI company says the new name reflects its expanded work with health systems, biopharma companies, and public health organizations.
Concurrence unifies health data in a foundation called the Health World Model, which provides patient context to clinicians and AI systems. Its workflows cover patient intake, medication management, and clinical decision support while recording patient interactions and clinical judgment.
The platform also identifies links between interventions and outcomes through what the company calls Patient Trajectories. It supports integrations with electronic health record systems from Epic Systems Corporation, Oracle Health, and athenahealth. Concurrence reports that its platform has handled more than 10 million patient interactions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and Optum Nov 10 Oura to Buy AI Care Company Counsel Health for $625 Million Nov 10 Dimer Health's AI-supported post-discharge team found unmet care needs in 23% of 680 hospital patients Nov 10 Google.org gives Clalit $2 million for a multilingual voice AI that books care for 5 million members Nov 10 Elomia Health acquires Earkick, an AI wellbeing companion used by more than 250,000 peopleLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
Azra AI Acquires Blackford Analysis
Andor Health Receives 2026 Frost & Sullivan Recognition for AI Care Orchestration
Consensus Unveils AI Demo Platform at DemoFest London
Accrete Secures Argus Contract Renewal From International Defense Partner
Daily AI Brief: the AI news that matters, in your inbox.